Skip to contentS
Sanara MedTech Inc.
S
SMTISanara MedTech Inc. Q1 2019 · 10-Q
Revenue$2.49M$2.49M+26.8% vs Q1 2018 Net Income-$162.57K-$162.57KN/M vs Q1 2018 EPS Diluted-$0.39-$0.39N/M vs Q1 2018 Gross Profit$2,197,556+25.5% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Sanara MedTech Inc. · CIK 714256 · Engraved from SEC EDGAR
Operating Cash Flow-$436,143N/M Free Cash Flowderived-$442,937N/M Margins · derivedGross margin88.4%−0.9 pt vs Q1 2018
Operating margin-6.3%−9.7 pt vs Q1 2018
Net margin-6.5%−6.9 pt vs Q1 2018
ended Mar 31, 2019 · filed May 20, 2019 · 50 d after period end